BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Drug Development

  Medarex, Inc.'s Ipilimumab Plus Chemotherapy is Associated with Prolonged Survival and Increased Disease Control Rates in Patients with Advanced Melanoma; Updated Clinical Phase 2 Data Presented at American Society of Clinical Oncology Annual Meeting

  June 2, 2008

   · 

  6 min read
• Drug Development

  Cell Genesys, Inc. Reports Updated Results From Phase 1 Clinical Trial of GVAX Immunotherapy for Prostate Cancer Used in Combination With Ipilimumab

  June 2, 2008

   · 

  1 min read
• Drug Development

  CuraGen Corporation Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity Of CR011-Vcmmae In Metastatic Melanoma - Data Presented At The 2008 American Society of Clinical Oncology Annual Meeting - - Conference Call To Be Hosted Wednesday,

  June 2, 2008

   · 

  7 min read
• Drug Development

  Novo Nordisk A/S and Neose Technologies, Inc. Announce Completion of Initial Phase 1 Clinical Trial of NN7128 (Long-Acting Factor VIIa)

  June 2, 2008

   · 

  1 min read
• Drug Development

  Oncolytics Biotech Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at American Society of Clinical Oncology Annual Meeting

  June 2, 2008

   · 

  3 min read
• Drug Development

  Quest PharmaTech Inc. Announces Positive Results from Phase I Clinical Trial of its Photodynamic Therapy for Actinic Keratosis TSX Venture: QPT

  June 2, 2008

   · 

  4 min read
• Business

  Applied Biosystems and BioTrove, Inc. Team Up to Improve Drug Discovery with High-Throughput Mass Spectrometry Applications

  June 2, 2008

   · 

  1 min read
• Business

  Raymedica, Inc. Announces New President, Craig Corrance

  June 2, 2008

   · 

  1 min read
• Drug Development

  Vion Pharmaceuticals Announces Presentation of Data from Phase III Trial of Cloretazine(R) (VNP40101M) and Cytarabine in Relapsed Acute Myelogenous Leukemia at the American Society of Clinical Oncology Annual Meeting

  June 2, 2008

   · 

  6 min read
• Biotech Bay

  Fluidigm Corporation Introduces First Integrated Fluidic Circuit Able to Perform 9,216 Simultaneous Real-Time PCR Experiments

  June 2, 2008

   · 

  1 min read